UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
Novartis for Alcon (ACL)? Novartis Says "No" But Market Says "Yes"
-
Despite Novartis Denial, UBS Makes A Strong Case That They Should Buy Alcon (ACL)
-
Citi Upgrades Novartis (NVS) to Buy After-Hours
-
Morning Movers 9/3: UPI, SVA, CRIS, BNVI, ZUMZ, VICL, MEDQ Higher; AMED, INWK, HOV, FDO, VG Lower
-
Unusual 11 Mid-Day Movers 8/7: OPXA, SPDE, CROX, BRKS Higher; LEAP, AINV, STV Lower
-
Notable Analyst Rating Changes 7/17: NVS, CHINA, CVLT, BT Upgraded; NOK, AKAM, KMP, SCHN, LL Downgraded
-
J.P. Morgan Upgrades Novartis (NVS) to Overweight
-
David Moenning's Daily State of the Markets: 10/16
-
Unusual 11 Mid-Day Movers 2/29: MNTA, JRJC, SAPE, COMS Higher; FMT, CDL, RHD, ABH Lower
-
Notable Analyst Rating Changes 2/29: PFE, DELL, DECK Upgraded; MF, JTX, TTWO Downgraded
